The association between CD3 + and CD8 + tumor-infiltrating lymphocytes (TILs) and prognosis in patients with pancreatic adenocarcinoma.

Autor: Panahi M; Gastrointestinal and Liver Diseases Research Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran., Rezagholizadeh F; Molecular and Cellular Research Center, Iran University of Medical Sciences, Tehran, Iran; Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran., Mollazadehghomi S; Gastrointestinal and Liver Diseases Research Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran; Department of Pathology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran; Immunology Board for Transplantation and Cell-Based Therapeutics (ImmunoTACT), Universal Scientific Education and Research Network (USERN), Tehran, Iran., Farhangnia P; Immunology Board for Transplantation and Cell-Based Therapeutics (ImmunoTACT), Universal Scientific Education and Research Network (USERN), Tehran, Iran; Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran; Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran., Niya MHK; Gastrointestinal and Liver Diseases Research Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran., Ajdarkosh H; Gastrointestinal and Liver Diseases Research Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran., Tameshkel FS; Gastrointestinal and Liver Diseases Research Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran., Heshmati SM; Gastrointestinal and Liver Diseases Research Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran; Department of Pathology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. Electronic address: Mooe_360@yahoo.com.
Jazyk: angličtina
Zdroj: Cancer treatment and research communications [Cancer Treat Res Commun] 2023; Vol. 35, pp. 100699. Date of Electronic Publication: 2023 Mar 25.
DOI: 10.1016/j.ctarc.2023.100699
Abstrakt: Background: Pancreatic adenocarcinoma (PDAC), with more than 250,000 deaths each year, is the eighth leading cause of death worldwide, with a five-year survival of less than 5% and a median recurrence time between 5 and 23 months. The association between PDAC and CD3 + /CD8 + tumor-infiltrating lymphocytes (TILs) and the extent of tumor spread and clinical outcomes has been recently shown. This study aimed to determine and compare the density of TILs and their association with disease prognosis in patients with PDAC.
Materials and Methods: In this study, we collected PDAC tissues and corresponding adjacent normal tissues from 64 patients with TIL-positive PDAC. The immunohistochemistry method was used for the detection of the expression levels of CD3 + and CD8 + TILs in PDAC tissues. Also, the completed follow-up history was evaluated for at least five years.
Results: The frequency of intratumoral and peritumoral TILs was 20 (31.2%) and 44 (68.8%), respectively. The mean density of CD3 + TILs and CD8 + TILs was 67.73%±20.17% and 69.45%±17.82%, respectively. The density of CD3 + TILs and CD8 + TILs was not associated with overall survival nor metastasis-free survival of the patients and tumor grade. However, the density of TILs was significantly lower in those patients who experienced tumor recurrence than those without this recurrence.
Conclusion: TILs density was high in patients with PDAC. The density of both CD3 + and CD8 + TILs was significantly lower in patients who experienced tumor recurrence. Thus, this study suggests that tracking and determining the density of CD3 + and CD8 + TILs might be effective in predicting PDAC recurrence.
Competing Interests: Declaration of Competing Interest There are no conflicting interests.
(Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: